Life on hold: The experience of living with neuromyelitis optica

Disability and Rehabilitation

Volumn 36, Issue 13, 2014, Pages 1100-1107

  Mutch, Kerry ^a   Methley, Abigail ^b   Moore, Phil ^a   Jacob, Anu ^a  

^a THE WALTON CENTRE NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Daily activities; Lived experience; Neuromyelitis optica; Qualitative research; Relapses

Indexed keywords

ADAPTIVE BEHAVIOR; ADOLESCENT; ADULT; AGED; DAILY LIFE ACTIVITY; DISABILITY; FEMALE; HUMAN; INTERVIEW; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; PATHOPHYSIOLOGY; PSYCHOLOGY; QUALITATIVE RESEARCH; RECURRENT DISEASE; SOCIAL SUPPORT;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGED; DISABILITY EVALUATION; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; QUALITATIVE RESEARCH; RECURRENCE; SOCIAL SUPPORT;

EID: 84902520926     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.3109/09638288.2013.833301     Document Type: Article

References (32)

1. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of Neuromyelitis Optica (Devic's Syndrome). Neurology 1999;53:1101-14
2. Jacob A, McKeon A, Nakashima I, et al. Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. J Neurol Neurosurg Psychiatry 2013;84:922-30
3. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004;364:2106-12. (Pubitemid 39626806
4. Palace J, Leite I, Nairse A, Vincent A. Interferon Beta treatment in neuromyelitis optica. Arch Neurol 2010;66:1016-17
5. Jacob A, Hutchinson M, Elsone L, et al. Does natalizumab therapy worsen neuromyelitis opticä. Neurology 2012;79:1065-6
6. Jacob A, Panicker J, Lythgoe D, et al. The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of UK. J Neurol 2013;260:2134-7
7. Asgari N, Lillevang S, Skejoe H, et al. A population-based study of neuromyelitis optica in Caucasians. Neurology 2011;76: 1589-95
8. Rivera J, Kurtzke J, Booth V, Corona VT. Characteristics of Devic's disease (neuromyelitis optica) in Mexico. J Neurol 2008; 255:710-15
9. Siritho S, Nakashima I, Takahashi T, et al. AQP4 antibody-positive Thai cases: Clinical features and diagnostic problems. Neurology 2011;77:736-42
10. Wingerchuk DM, Weinshenker BG. Neuromyelitis optica: Clinical predictors of a relapsing course and survival. Neurology 2003;60: 848-53. (Pubitemid 36297372
11. Palace J, Leite I, Jacob A. A practical guide to the treatment of neuromyelitis optica. Pract Neurol 2012;12:209-14
12. Collongues N, De Seze J. Current and future treatment approaches for neuromyelitis optica. Ther Adv Neurol Disord 2011;4:111-21
13. Kanamori Y, Nakashima I, Takai Y, et al. Pain in neuromyelitis optica and its effect on quality of life: A cross-sectional study. Neurology 2011;77:652-8
14. Elsone L, Townsend T, Mutch K, et al. Neuropathic pruritus (itch) in neuromyelitis optica. Mult Scler 2012;19:475-9
15. Kim SM, Go MJ, Sung JJ, et al. Painful tonic spasm in neuromyelitis optica: Incidence, diagnostic and clinical characteristics. Arch Neurol 2012;69:1026-31
16. Miller CM. The lived experience of relapsing Multiple Sclerosis: A phenomenological study. J Neurosci Nurs 1997;29:294-304
17. Boeje H. A purposeful approach to the constant comparative method in the analysis of qualitative interviews. Qual Quant 2002;36: 391-409
18. Ritchie J, Lewis J. Qualitative research practice. A guide for social science students and researchers. London: Sage; 2007
19. Squire R. Living well with rheumatoid arthritis. Musculoskeletal Care 2012;10:127-34
20. Mozo-Dutton L, Simpson J, Boot J. MS and me: Exploring the impact of multiple sclerosis on perceptions of self. Disabil Rehabil 2012;34:1208-17
21. Menzin J, Caon C, Nichols C, et al. Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis. J Manag Care Pharm 2013;19:S24-40
22. Coulter A, Ellins J. Effectiveness of strategies for informing, educating and involving patients. BMJ 2007;335:24-7. (Pubitemid 47066902
23. De Broe S, Christopher F, Waugh N. The role of specialist nurses in multiple sclerosis: A rapid and systematic review. Health Technol Assess 2001;5:1-52
24. Hepworth M, Harrison J. A survey of the information needs of people with Multiple Sclerosis. Health Inform J 2004;10:49-69. (Pubitemid 38780092
25. Malcomson KS, Lowe-Strong AS, Dunwoody L. What can we learn from the personal insights of individuals living and coping with multiple sclerosis?. Disabil Rehabil 2008;30:662-74
26. Jannings W, Pryor J. The experiences and needs of persons with spinal cord injury who can walk. Disabil Rehabil 2012;34: 1820-26
27. Kennedy P, Rogers BA. Anxiety and depression after spinal cord injury: A longitudinal analysis. Arch Phy Med Rehabil 2000;81: 932-7. (Pubitemid 30460809
28. Nicholls E, Lehan T, Plaza SL, et al. Factors influencing acceptance of disability in individuals with spinal cord injury in Neiva, Columbia, South America. Disabil Rehabil 2012;34:1082-8
29. Weitzner E, Sarca S, Wiese S, et al. Getting on with life: Positive experiences of living with a spinal cord injury. Qual Health Res 2011;21:1455-68
30. Nyman S, Dibb B, Victor C. Emotional well-being and adjustment to vision loss in later life: A meta-synthesis of qualitative studies. Disabil Rehabil 2012;34:971-81
31. Sharpe L, Curran L. Understanding the process of adjustment to illness. Soc Sci Med 2006;62:1153-66. (Pubitemid 43129580
32. Baker LM. Sense making in multiple sclerosis: The information needs of people during an acute exacerbation. Qual Health Res 1998;8:106-20.